Health Canada
- Status: approved
evaluation of propofol effect using BIS (evaluation of propofol effect using BIS) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Universidad del Desarrollo is the originator. The local marketing authorisation holder may differ — check the official source linked above.